(A) SUMO5 interacts specifically with SUMO E3 enzymes PIAS1 and Pc2. Flag-SUMO5 or Flag-SUMO5(AA) were cotransfected into 293 cells with HA-tagged Pc2, PIAS1, or PIASx-α. Anti-Flag immunoprecipitates (IP) of cell lysates were immunoblotted (IB) with anti-Flag or anti-HA antibodies as indicated. (B) Comparison of the protein structures of SUMO5, SUMO1, and SUMO2. The structures of SUMO1 (Protein Data Bank code 1A5R), SUMO2 (PDB code 2AWT), and SUMO5 (predicted structure using PDB code 1A5R as template) were generated using the Cn3D program. Magenta, secondary structures. Yellow, the conserved SUMO modification motif (ΨKXE). (C) SUMO5(H12D) and SUMO5(I95T) form nuclear bodies. Localization of GFP-tagged SUMO5(H12D) and SUMO5(I95T) and their associated NBs were assessed by confocal microscopy after transfection in 293 cells. DNA (blue) was stained with DAPI. (D) Co-expression of SUMO5 and SUMO5(sm) results in a loss of NBs. Scale bars, 10 µm. Endogenous SP100 partially co-localizes with SUMO5 in the nucleus in the presence of PML-RARα. 293 cells were transfected with GFP-tagged SUMO5 alone or cotransfected with GFP-SUMO5 and HA-PML-RARα. An antibody specific for SP100 was used to gauge the localization of endogenous SP100 in confocal microscopy. (E) HIPK2 partially co-localizes with SUMO5 in the nucleus in the presence of PML-RARα. 293 cells were transfected with combinations of plasmids indicated at the left of the panels. Subcellular localization of GFP-SUMO5 and Flag-HIPK2 was analyzed by confocal microscopy. (F) shSUMO5 specifically knocks down the expression of SUMO5. 293 cells were cotransfected with GFP-SUMO expression plasmids and the shRNA construct for SUMO5 or control shRNA (shNC). (G) Summary of the consequences of SUMO5 conjugation in pathological conditions such as APL. In the presence of PML-RARα, SUMO5 preferentially conjugates PML-RARα, resulting in decreased SUMO5 conjugation of PML. SUMO5-conjugated PML-RARα sequesters PML into the cytoplasm, leaving behind nuclear bodies without PML. Scale bars, 10 µm. (H) Summary of how SUMO5 regulates the PML-NB cycle. Mono-conjugation of PML by SUMO5, which is the seeding phase of PML-NB biogenesis, creates a platform upon which components of PML-NBs assemble through interaction and further SUMO5 conjugation. Enlargement of PML-NBs is facilitated by polySUMO5 conjugation of PML, which recruits other proteins into PML-NBs. Conjugation of SUMO2/3 and concomitant de-conjugation of SUMO5 from PML initiate the disruption process of PML-NBs.
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Figure S8. SUMO5-mediated nuclear bodies are involved in DNA damage response.
